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Abstract: Aspartic acid, or “aspartate,” is a non-essential, four carbon amino acid produced and used
by the body in two enantiomeric forms: L-aspartic acid and D-aspartic acid. The L-configuration
of amino acids is the dominant form used in protein synthesis; thus, L-aspartic acid is by far the
more common configuration. However, D-aspartic acid is one of only two known D-amino acids
biosynthesized by eukaryotes. While L-aspartic acid is used in protein biosynthesis and neuro-
transmission, D-aspartic acid is associated with neurogenesis and the endocrine system. Aspartic
acid production and use has been growing in recent years. The purpose of this article is to discuss
various perspectives on aspartic acid, including its industrial utility, global markets, production and
manufacturing, optimization, challenges, and future outlook. As such, this review will provide a
thorough background on this key biochemical.
Keywords: bio-based; bio-chemicals; bio-materials; fermentation; synthesis
1. Industrial Utility
In addition to its biofunctionality, aspartic acid has wide application in the food,
beverage, pharmaceutical, cosmetic, and agricultural industries [1]. L-aspartic acid is used
as a nutritional supplement in both functional foods and beverages, but its primary use
is in combination with the amino acid phenylalanine which together make aspartame,
an artificial sweetener [2]. Aspartic acid is also used to bolster immune function and
as a natural combatant to depression [1]. Its ability to aid in energy production, fatigue
resistance, RNA and DNA synthesis, and liver detoxification give it broad clinical use [1].
Additionally, it is used as an intermediary substrate in the manufacture of pharmaceuticals
and organic chemicals, serving as the building block molecule for active pharmaceutical
ingredients [1]. Aspartic acid’s utility stretches further upon consideration of its derivatives
including acetyl aspartic acid, used as an active ingredient in anti-aging cosmetics that
target wrinkling, skin lifting, and loss of firmness [3]. It is also used to produce polyaspartic
acid, a fertilizer synergist which increases both nitrogen absorption and crop yields [4].
Polyaspartic acid hydrogels are a type of biodegradable superabsorbent polymer which
have exceptional water-holding abilities and are used in the production of many modern
amenities including diapers, feminine products, and engineered tissue [5]. The range and
depth of aspartic acid’s applicability, in particular the L-configuration, has placed it on the
Department of Energy’s Top Value Added Chemicals from Biomass list [2].
2. Global Markets
The global aspartic acid market is a highly fractionated market meaning it consists
of several small company players rather than large conglomerates, yet it is growing with
significant potential for industrial relevance [6]. According to a 2015 report by Grand
View Research, the global aspartic acid market is projected to reach $101 million with a
market demand of 60.6 kilotons by 2022 which represents a compound annual growth
rate of 5.6% [6]. As of 2014, the baseline year of said report, polyaspartic acid represented
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22.6% of the total aspartic acid market volume making it the largest market segment,
seconded by aspartame [6]. Both aspartic acid derivatives are anticipated to increase in
demand as polyaspartic biodegradable polymers replace polyacrylic acid in agriculture,
water treatment, and the petrochemical industries and as food and beverage trends shift
towards added sugar labeling and health-conscious, convenience foods [6]. Of all aspartic
acid market sectors, the medical sector is projected to grow the most as is attributed to the
American healthcare system, which is housed in the largest regional market, accounting
for 39.0% of total aspartic acid volume as of 2014 [6]. Internationally increased demand
for aspartic acid is also expected to increase in the form of greater aspartame demand for
carbonated beverages in Asia Pacific [6].
3. Production and Manufacturing
There are three main methods to produce aspartic acid: protein extraction, chemical
synthesis, and enzymatic conversion [2]. The hydrolysis of protein for extraction methods
produces an abundance of amino acids from which the L-aspartic acid must be separated.
Chemical synthesis requires high temperature and pressure and results in a racemic mix-
ture, producing both L- and D-isomers thereby requiring the additional processing steps
of optical resolution and racemization to achieve the preferred L-isomer [1]. Thus, enzy-
matic conversion is the currently favored route of production. The enzymatic conversion
process exists in two forms: simple enzyme-substrate interaction (hereafter referred to as
“enzymatic conversion”) or whole-cell enzymatic conversion, i.e., fermentation. Table 1
summarizes various economic and technical aspects of the production of aspartic acid.
Stereospecific, industrial production of L-aspartic acid currently utilizes a one-step re-
action of fumaric acid, in the presence of high concentrations of ammonia, to L-aspartic acid
via L- aspartate ammonia-lyase, an enzyme also referred to as “L-aspartase” (Figure 1) [7].
L-aspartase can be purified and immobilized in a gel matrix for continuous production
or overexpressed in bacterial cells bound to polyurethane carriers [7]. Production via
immobilized enzymatic conversion or bacterial fermentation utilizes the same enzyme and
substrate; however, enzymatic production is favored for its high product concentration,
productivity, minimal byproducts, and the ease of downstream processing [2]. Yet, fermen-
tative production, albeit less productive, has been around since the 1950s when research
and development into the production of aspartic acid began [8].
While several species of bacteria including select Pseudomonas, Bacillus, and Proteus
have been identified as producers of aspartic acid, E. coli and Cornybacterium glutamacium
are nearly exclusively used by industry [1,9]. Fumaric acid is the primary substrate in
L-aspartic acid production; however, maleate, a less expensive feedstock, can be used in a
two-step reaction which uses maleate isomerase to convert maleate to fumaric acid which
is then converted via L-aspartase to L-aspartic acid in the presence of ammonium ions [8].
The basic fermentation process, as developed and patented in the 1960s, utilizes
a sugar-free medium wherein fumaric acid is the sole source of carbon subsequently
minimizing the production of unwanted byproducts [10]. Ammonia, while required for
catalysis, also serves as the nitrogen source and is formulated at a 1:1 or 1:2 fumaric
acid-ammonia ratio [10]. Prior to inoculation, the broth pH is initialized to 7.0 and left
unregulated as it will naturally increase to a 8.4–9.6 range in the initial stages of the
fermentation, allowing for the production of acid [10].
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Figure 1. Chemical mechanism of aspartic acid production (based, in part, on [8]).
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Table 1. Summary of Aspartic Acid Supply Chain, Economic and Technological Considerations for Aspartic Acid Production.
Category Summary
Industrial importance and potential of biochemical
Aspartic acid is used in the food, beverage, pharmaceutical, cosmetic, and agricultural industries.
The global aspartic acid market is projected to reach $101 million with a market demand of 60.6
kilotons by 2022 representing a compound annual growth rate of 5.6% [6].
Industrial uses for biochemical
Aspartic acid is used in the production of: nutritional (amino acid) supplements; artificial
sweetener (aspartame); polyaspartic acid hydrogels; and acetyl aspartic acid, the active ingredient
in anti-aging cosmetics.
Substrates used for the production of biochemical
primary substrate: fumaric acid [7]
cofactor: ammonia [7]
enzyme: L-aspartate ammonia-lyase [7]
Microorganisms used for fermentation







What enzymes are needed to break down the substrate for fermentation Fumaric acid used in aspartic acid production does not need to be broken down, rather, it isfermentatively produced from glucose or chemically produced from maleic anhydride [6].
Fermentation conditions used: pH, substrate loading, temperatures, times, maximum yield,
maximum fermentation rates
pH is initialized to 7.0 [10]
substrate concentration: 1:1 or 1:2 ammonia to fumaric acid [10]
time 2 to 10 days [10]
temperature 27–40 ◦C [10]
yield 77–95% (w/w of fumaric acid) depending on bacterial strain and fermentation conditions [10]
Separation equipment, conditions, efficiencies batch fermentation: separation via anion exchange column and crystallization [10]continuous fermentation: separation via isoelectric point precipitation and crystallization [10]
Total energy used to produce this chemical Data not currently published.
Estimated costs to produce this chemical
Cost as well as upstream and downstream raw materials and equipment analysis available in the
global L-aspartic acid market report provided by Market Watch (2019), at
https://www.researchreportsworld.com/purchase/14314090 (accessed on 21 February 2021)
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Table 1. Cont.
Category Summary
Current aspartic acid manufacturers
The following companies are the top industrial producers of aspartic acid [11]; the corresponding
links, when applicable, are to each respective company’s product information page.
Ajinomoto Group




0ZWZjLThjNmUtODFiYjQ3YmYwM2I2 (accessed on 21 February 2021)
KYOWA
http://www.kyowahakko-bio.co.jp/english/products/aminoacids/l_aspartic_acid/ (accessed
on 21 February 2021)
Jinghai Amino Acid
http://en.chinaaminoacid.com/products/L-AsparticAcid.shtml (accessed on 21 February 2021)
JIRONG PHARM
Not currently available OR product catalogue not in English
Siwei Amino Acid
English product description not available
Zhangjiagangxingyu Technology
http://www.zjgxykj.com/template/p13e.html (accessed on 21 February 2021)
Hubei Bafeng Pharmaceutical
Company page not accessible in English
Potential market segments, sales, etc.
The aspartic acid market is segmented into six market categories: Feed Supplements, Medicine,
Polyaspartic Acid, Aspartame, L-Alanine, and “Others” [6]. The report summary states that
polyaspartic acid represents 22.6% of the total market volume in 2014. Market volumes and revenue
values available upon report purchase [11].
Primary economic setbacks and challenges
Fermentative production competes economically with petroleum-derived production. Economic
setbacks of aspartic acid include high fumaric substrate cost and the low yields currently achieved
by switching to cheaper sugar-based feedstocks [10]. Crystallization utilized in downstream
processing separations can be expensive and time-consuming [1].
Technological setbacks and challenges
The fermentative production of aspartic acid from glucose or sugar-based feedstocks, both much
cheaper and more available substrates than fumarate, currently generate much poorer yields, i.e.,
95% versus 29% [8]. Thus, the main technological setback to more economical aspartic acid
production is the ability to directly ferment sugar to L-aspartic acid.
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Table 1. Cont.
Category Summary
Side products, byproducts, waste products and associated cost
Organisms whose genomes also code fumarase (e.g., C. glutamicum, E. coli) produce malic acid from
fumarate as a byproduct in effect utilizing substrate and decreasing aspartic acid yield. Without
heat treatments Tajima et al. (2015) lost 25% of the fumaric acid substrate to malic acid production
which translates to significant yield losses [7].
Downstream processing operations
L-aspartic acid can be separated from the culture broth or eluate in batch systems via ion exchange
resins utilizing an anion exchange column followed by crystallization of the eluate [1]. Continuous
systems can extract the L-aspartic acid via isoelectric point precipitation (adjust broth pH to 2.8)
followed by crystallization [10].
New technologies, strains, equipment developments
Membrane reactor systems (MRS), as they are currently being developed, utilize growth-arrested
cells eliminating the need for cell or enzyme immobilization [8]. The MRS system employed by
Yukawa et al. (2009) overcomes the low mass transfer rates and low volumetric productivity issues
associated with immobilization systems and simplifies the overall production process, allowing for
easier separation of cells from the reaction mixture and generating high yield and productivity
during long periods of operation [8].
Genetic modification of the metabolic pathways and feedback regulators within E. coli and C.
glutamicum, the two major strains involved in industrial amino acid synthesis, are the next steps in
improving L-aspartic acid production via the development of new, high-producing strains.
Fermentation 2021, 7, 49 6 of 12
Fermentation can be conducted with or without agitation for 2 to 10 days at 27–40 ◦C [10].
The L-aspartic acid will be extracellularly secreted and accumulate in the culture broth [10].
Several methods of downstream processing are available to separate L-aspartic acid from
the culture broth or eluate. In the case of batch fermentation, ion exchange resins can be
used to separate and purify the L-aspartic acid on an anion exchange column followed
by crystallization of the eluate (Figure 2). For continuous fermentation, L-aspartic acid
can be separated by adjusting the broth to 90 ◦C and a pH of 2.8 with sulfuric acid [10].
Adjusting the pH to 2.8, i.e., the isoelectric point, will cause L-aspartic acid to precipitate
out of solution where it is then subjected to a two hour incubation period at 15 ◦C to
induce protein crystallization [10]. Under these conditions, 95% of the theoretical yield of
L-aspartic acid was achieved by Masahiro et al. (1965) which aligns with the 77–95% yield
range achieved similar fermentation processes utilizing various bacterial strains [1,10].
Table 2 provides commonly used L-aspartic acid fermentation parameters.
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Table 2. Specific Production Parameters for the Fermentative Synthesis of Aspartic Acid.
Yukawa et al. (2009) [8] Tajima et al. (2015) [7] Chibata et al. (1986) [13] Szymanska et al. (2011) [14] Papierz et al. (2007) [15]
Pretreatments and
Conditions Used
Genetically modify C. glutamicum
to overproduce maleate
isomerase and aspartase
E. coli DH5 used to produce
plasmid containing aspA gene
which is inserted into S.
livingstonensis; sonicate then heat
treat cells
Entrap E. coli in polyacrylamide gel
via polymerization reaction then
break gel in 3–4 mm diameter
granules; wash granules in water
Immobilize cells in chitosan gel;
culture in FF medium for biomass
cultivation (or other chemically
defined media as outlined on pg. 2)
Cell membrane permeabilization
activates cells prior to aspartic
acid production; perfomed in
activation medium (chemically
defined pg. 2) at 37 ◦C for 48 h
Substrate Used Maleate ammonium fumarate-NH3
1 M ammonium fumarate used for
aspartic acid production by
immobilized aspartase but no
mention if substrate changed in
subsequent trials
ammonium fumarate fumaric acid
Substrate Loadings Specifics not published 860 mM fumarate-NH3 solution(pH 9)
417 mM/h ammonium fumarate
used for aspartic acid production
by immobilized aspartase no
mention if substrate loading
changed in subsequent trials
150.0 g/L ammonium fumarate
100g/L fumaric acid
1 g biomass into 10 mL
production media
Enzymes Used maleate isomerase, aspartase Enzymes are generatedintracellularly intracellular aspartase intracellular aspartase intracellular aspartase
Enzyme Loadings Specifics not published Not applicable Not applicable Not applicable Not applicable
Reaction Times production is continuous 1–2 h
enzyme activity observed after
24–48 h found in production media;
however, production can expands
weeks in a continuous reactor
>603 h (production can
be continuous) 18–30 h
Bioreactor Conditions pH 8.5Temp 30 ◦C
Heat treatment prior to
fermentation performed in water
bath; optimal conditions were 50
◦C for 15 min
intended for continuous
production; pack cells in a
column reactor
biocatalyst bed height to volume
ratio = 3:1;
liquid hour space velocity value
was 5.2 (i.e., volume of feeding
substrate passed per volume of
catalyst in bioreactor per one hour)
100 mL shake flasks
Microorganisms Used C. glutamicum S. livingstonensis E. coli ATCC 11303 Escherichia coli mutant strains B-715and P1
Escherichia coli mutant strain
B-715
Fermentation Conditions
Used (Temp, pH, etc.)
pH 8.5
Temp 30 ◦C
whole cell production set at 37 ◦C
for 3 h
Temp 37 ◦C
half-life of column was 120 days
initial media pH 8.5
Temp 40 ◦C





separated by HPLC with RI
detector and ion exclusion column
Specifics not published HPLC HPLC
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Table 2. Cont.
Yukawa et al. (2009) [8] Tajima et al. (2015) [7] Chibata et al. (1986) [13] Szymanska et al. (2011) [14] Papierz et al. (2007) [15]
Separation
Conditions Used Specifics not published
Eluate at 60 ◦C using 0.1% (v/v)
phosphoric acid for mobile




HPLC with 250–4 LichrospherTM
100RP-18 (Merck) column and
Waters fluorescence detector
Deproteinize with methanol,
centrifuge, then run on HPLC
column set to a flow-rate of 1
mL/min, 22 ◦C, and 2100 PSI
with mobile phase of 200 mL





productivity” hints that it
should be within >95% range




Immobilized aspartase had 29% activity
yield but this “activity yield and the
stability of the immobilized enzyme were
not satisfactory for industrial purposes”
thus the need to increase yield from this
starting point in subsequent trials; for the
set of conditions listed here, the results only
mention that activity was notably increased
99.8% conversion rate
6 g L-aspartic acid/g of cells /hour
0.19–0.35 g L-aspartic acid/g of





L-malic acid is a byproduct
(reduces yield) which can be
avoided by inactivating
fumarase via incubation at
45 ◦C for 5 h
L-malic acid also major
byproduct (reduces yield)
Increased membrane permeability to
substrate (“activation”) and later product
increases enzyme activity and is the result
of autolysis of the cells in the gel; Tween 80
required for E. coli P1
Better immobilization and aspartic
acid production with added
surfactants for cell activation and a
media 2-fold lower in yeast extract
(found to be an inhibitory
ingredient for biomass production)
Improved production following
incubation in the activation
medium containing 5 g/L
ammonium fumarate
Notes Incredibly limited in methoddetail and results
Exact methodology published,
even greater detail in literature
since multiple fermentation
conditions were tested.
Review is very dated (1986); however, it
covers several additional methods utilizing
different gels and optimized parameters of
base method. It appears to contain
foundational work from which the popular
immobilization technique of aspartic acid
production was developed.
Highly detailed methodology
L-aspartic acid production was
used to determine best
aspartase-active mutant strain,
i.e., conditions may not reflect
requirements for scaled-up
industrial production
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4. Optimization
Traditional fermentation setups have since been adapted and optimized to increase
productivity and process efficiency. Most notable is the development of continuous systems
such as the one employed by Tosa et al. (1973) using immobilized E. coli on a cell column.
Tosa et al. found production to be optimal at pH 8.5, 50 ◦C, and a maximized media flow
rate of space velocity, i.e., the ratio of volumetric flow rate to reactor volume, of 0.8 [16].
Further process improvement included fortification of the fermentation medium with
divalent cations (Mg+2, Mg+2, Ca+2) as was found to protect cells from heat inactivation
subsequently increasing the stability of the column [16].
More recently, membrane reactor systems (MRS) are being developed, the use of
growth-arrested cells eliminating the need for immobilization (Figure 3) [8]. The MRS
system employed by Yukawa et al. (2009) overcomes the low mass transfer rates and low
volumetric productivity issues associated with immobilization systems and simplifies the
overall process, allowing for easier separation of cells from the reaction mixture and gener-
ating high yield and productivity during long periods of operation [8]. While industrial
L-aspartic acid production began with immobilized enzymes or cells, it has progressed to
include both fermentative and membrane reactor systems [8].
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Figure 3. Example membrane reactor system for continuous production of aspartic acid (adapted
from [8]).
5. Challenges
According to the U.S. Department of Energy, the major challenges confronting the
development of biomass-gen rated L-aspartic acid as a j r emical building block for
the synthesis f multiple high-value biochemicals and materials include: the development
of an economically comparable, direct fermentation process from sugar to L-aspartic acid
or reduction in the cost of fumaric acid for current production ethods [2].
Fermentable sugars are the target substrate for L-aspartic acid production due to
their abundance and low cost but are not yet realizable due to the low yields currently
achieved [8]. Production of L-aspartic acid from fumaric acid is a one-step reaction and is
currently preferred for its higher yields, achieving over 95% yield as compared to 29% from
fermentable sugars [8]. While the market price and operational expenses of L-aspartic acid
production and its substrates are not free-access, the cost reduction in transitioning from
a fumaric acid substrate to glucose or other sugar from biomass represents a significant—
nearly 4.5 times less expensive—cost saving as seen by comparing the 2020 retail price
of PharmaGrade fumaric acid to USP grade dextrose [17]. However, such cost savings
cannot be capitalized upon until improvements in the yield of sugar-based L-aspartic acid
fermentation are achieved.
The fermentative synthesis of L-aspartic acid from glucose occurs via the direct conver-
sion of oxaloacetate or fumarate, two interconvertible intermediates within the citric acid
cycle, into L-aspartic acid [18]. The maximum theoretical yield based on sugar reducing
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equivalents from either aforementioned intermediate is 2 mol L-aspartic acid per 1 mol
glucose [18]. Direct fermentation of glucose to L-aspartic acid is rarely reported within
the literature and when so, the associated yields are low even for known aspartic acid
producing strains, e.g., Brevibacterium flavum and Corynebacterium glutamicum were reported
to produce 0.30 mol and 1.02 mol L-aspartic acid per mol glucose, respectively [18]. Work
involving metabolic engineering to maximize L-aspartic acid yield on glucose, in particular
within industrially relevant strains such as E. coli, is severely lacking.
Recent work by Piao et al. (2019) has demonstrated that cost-effective fermentation of
L-aspartic acid from biomass is possible through the use of metabolically engineered E. coli
and as such is the first work to demonstrate metabolic optimization achieving substantive
yields of L-aspartic acid production from glucose [18]. Piao et al. were able to generate
a final titer of 33.1 g/L for a 21 h fed-batch fermentation which correlates to a yield of
1.01 mol/mol glucose, i.e., approximately 50% of the maximum theoretical yield [18]. While
successful proof-of-concept of an efficient route for the production of L-aspartic acid within
E. coli, this groundbreaking work elicits the need for further studies that address two
current challenges in the production of maximal stoichiometric yields of L-aspartic acid.
First, L-aspartic acid is an intermediate for a wide array of downstream metabolic reac-
tions and the precursor molecule to over ten different metabolic pathways thereby making
it difficult to accumulate large quantities of L-aspartic acid mid-metabolism [18]. Further
studies need address this bottleneck through metabolic redesign that favors L-aspartic acid
accumulation or the development of fermentation strategies that target production of the
final L-aspartic acid derivative generated via irreversible reactions. The second challenge
is to identify the key to maximum theoretical yield of L-aspartic acid via fermentative
synthesis which is currently not known due to the function of its precursor molecule,
oxaloacetate, as a critical molecule within several carbon metabolic pathways including
glycolysis and gluconeogenesis. This missing key to comprehensive metabolic design
strategy makes identification of key bottlenecks in L-aspartic acid accumulation complex
and as yet, unelucidated [18]. In addition to designing an optimized metabolic pathway,
optimization of a fermentation strategy, growth media, and operational parameters to sup-
port the growth and physiological metabolism of E. coli genetically modified for L-aspartic
acid production needs to be developed [18].
Until such improvements are met, reducing the production cost of fumaric acid is the
most economical alternative. Like aspartic acid synthesis, fumaric acid is metabolically
produced from oxaloacetate which is converted to malic acid by malate dehydrogenase
and then to fumaric acid via fumarase [19]. Several microbial species naturally synthesize
fumaric acid, but Rhizopus, a type of saprophytic fungi, are considered the best producer
for industrial scalability [19]. Engel et al. (2008) investigated fermentative fumaric acid
production from glucose as compared to petroleum-based chemical synthesis. While the
fermentative process yields are lower than chemical synthesis (85% w/w versus 112% w/w)
and the cost effectiveness of fermentation heavily dependent on the price of both oil and
glucose, the fermentation pathway shows economic potential especially considering the
additional process efficiencies achievable with metabolic engineering [20]. Thus, critical
developments in the production of fumaric acid particularly in regard to strain improve-
ment, fungal morphological control, cheaper substrate utilization, as well as upstream and
downstream yield and process efficiencies [19] will have a trickle-down effect upon the
production of aspartic acid.
6. Summary and Future Outlook
The development of bio-based chemicals and processes represents an invaluable op-
portunity in the protection of natural resources, reduced reliance on limited fossil fuels,
and byproduct optimization. Aspartic acid plays a role in the development of resource
sufficiency as a biodegradable superabsorbent polymer, a natural source of protein, and
as a renewable pharmaceutical, nutritional, and cosmetic compound. While continuous
columns and membrane reactor systems have advanced aspartic acid production from
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where it began in the 1950s, future developments taking advantage of modern genetic
modification and engineering can direct its future as a bio-based building block to meet
increasing market demand. In order to be competitive against petrochemically derived
aspartic acid, bio-based production calls for improvements in direct fermentative produc-
tion, i.e., development of a one-step glucose to aspartic acid process; reducing the cost of
fumaric acid; increasing sugar-based fermentation yields.
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